|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, C:
E.C.2.7.11.22
- Cyclin-dependent kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + a protein = ADP + a phosphoprotein
|
 |
 |
 |
 |
 |
ATP
|
+
|
protein
|
=
|
ADP
|
+
|
phosphoprotein
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
cyclin-dependent protein kinase holoenzyme complex
|
15 terms
|
 |
|
Biological process
|
regulation of gene silencing
|
31 terms
|
 |
|
Biochemical function
|
nucleotide binding
|
12 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
EMBO J
19:2877-2888
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of a gamma-herpesvirus cyclin-cdk complex.
|
|
G.L.Card,
P.Knowles,
H.Laman,
N.Jones,
N.Q.McDonald.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Several gamma-herpesviruses encode proteins related to the mammalian cyclins,
regulatory subunits of cyclin-dependent kinases (cdks) essential for cell cycle
progression. We report a 2.5 A crystal structure of a full-length oncogenic
viral cyclin from gamma-herpesvirus 68 complexed with cdk2. The viral cyclin
binds cdk2 with an orientation different from cyclin A and makes several novel
interactions at the interface, yet it activates cdk2 by triggering
conformational changes similar to cyclin A. Sequences within the viral cyclin
N-terminus lock part of the cdk2 T-loop within the core of the complex. These
sequences and others are conserved amongst the viral and cellular D-type
cyclins, suggesting that this structure has wider implications for other
cyclin-cdk complexes. The observed resistance of this viral cyclin-cdk complex
to inhibition by the p27(KIP:) cdk inhibitor is explained by sequence and
conformational variation in the cyclin rendering the p27(KIP:)-binding site on
the cyclin subunit non-functional.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2 (A) Structure of the M-cyclin–cdk2 complex. Cdk2 is
shown in blue except for the PSTAIRE region (residues 38–56)
in red and the T-loop (residues 146–166) in yellow. M-cyclin
is shown in gold. (B) An equivalent view following rotation by
90° about the horizontal axis. The T-loop forms two
antiparallel -strands,
which are sandwiched between the PSTAIRE helix and the
N-terminal region of M-cyclin. This figure and Figure 3A were
prepared using PREPI (S.Islam and M.J.Sternberg, unpublished).
(C) Highly schematic view of the two cyclin–cdk interfaces
illustrating key structural elements and selected interface
residues. The left hand panel is M-cyclin–cdk2, the right hand
panel is cyclin A–cdk2. Colours for the indicated secondary
structures follow (A) and Figure 3A.
|
 |
Figure 4.
Figure 4 (A) Surface representation of M-cyclin (gold, left) and
cyclin A (purple, right) bound to their respective cdk2 partners
(cyan C[ ]worm).
The cdk2 PSTAIRE region is shown in red and the T-loop in yellow
for both complexes as in Figure 2. The green surface of M-cyclin
and cyclin A indicates the hydrophobic patch, which packs
against the PSTAIRE helix. The shift in position of M-cyclin
relative to cyclin A can be seen as well as the different
contacts to the PSTAIRE helix. (B) Close-up of the hydrophobic
patch of M-cyclin–cdk2 and cyclin A–cdk2 revealing
differences in their interface contacts. (C) Stereo view of a
conserved cyclin–cdk2 interaction centred on the salt bridge
between K104^M and E133^M (top view) equivalent to K266^A and
E295^A (bottom view) as described in the text. Certain residues
in this region are omitted for clarity.
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by Macmillan Publishers Ltd:
EMBO J
(2000,
19,
2877-2888)
copyright 2000.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
E.Barton,
P.Mandal,
and
S.H.Speck
(2011).
Pathogenesis and host control of gammaherpesviruses: lessons from the mouse.
|
| |
Annu Rev Immunol, 29,
351-397.
|
 |
|
|
|
|
 |
M.Rabiller,
M.Getlik,
S.Klüter,
A.Richters,
S.Tückmantel,
J.R.Simard,
and
D.Rauh
(2010).
Proteus in the world of proteins: conformational changes in protein kinases.
|
| |
Arch Pharm (Weinheim), 343,
193-206.
|
 |
|
|
|
|
 |
S.H.Speck,
and
D.Ganem
(2010).
Viral latency and its regulation: lessons from the gamma-herpesviruses.
|
| |
Cell Host Microbe, 8,
100-115.
|
 |
|
|
|
|
 |
Z.Wang,
Y.Xie,
L.Zhang,
H.Zhang,
X.An,
T.Wang,
and
A.Meng
(2008).
Migratory localization of cyclin D2-Cdk4 complex suggests a spatial regulation of the G1-S transition.
|
| |
Cell Struct Funct, 33,
171-183.
|
 |
|
|
|
|
 |
J.L.Chung,
W.Wang,
and
P.E.Bourne
(2007).
High-throughput identification of interacting protein-protein binding sites.
|
| |
BMC Bioinformatics, 8,
223.
|
 |
|
|
|
|
 |
K.Baek,
R.S.Brown,
G.Birrane,
and
J.A.Ladias
(2007).
Crystal structure of human cyclin K, a positive regulator of cyclin-dependent kinase 9.
|
| |
J Mol Biol, 366,
563-573.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Sridhar,
N.Akula,
and
N.Pattabiraman
(2006).
Selectivity and potency of cyclin-dependent kinase inhibitors.
|
| |
AAPS J, 8,
E204-E221.
|
 |
|
|
|
|
 |
J.W.Upton,
and
S.H.Speck
(2006).
Evidence for CDK-dependent and CDK-independent functions of the murine gammaherpesvirus 68 v-cyclin.
|
| |
J Virol, 80,
11946-11959.
|
 |
|
|
|
|
 |
A.J.Bordner,
and
R.Abagyan
(2005).
Statistical analysis and prediction of protein-protein interfaces.
|
| |
Proteins, 60,
353-366.
|
 |
|
|
|
|
 |
C.Swanton
(2004).
Cell-cycle targeted therapies.
|
| |
Lancet Oncol, 5,
27-36.
|
 |
|
|
|
|
 |
L.A.Dourmishev,
A.L.Dourmishev,
D.Palmeri,
R.A.Schwartz,
and
D.M.Lukac
(2003).
Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.
|
| |
Microbiol Mol Biol Rev, 67,
175.
|
 |
|
|
|
|
 |
M.C.Morris,
C.Gondeau,
J.A.Tainer,
and
G.Divita
(2002).
Kinetic mechanism of activation of the Cdk2/cyclin A complex. Key role of the C-lobe of the Cdk.
|
| |
J Biol Chem, 277,
23847-23853.
|
 |
|
|
|
|
 |
U.Schulze-Gahmen,
and
S.H.Kim
(2002).
Structural basis for CDK6 activation by a virus-encoded cyclin.
|
| |
Nat Struct Biol, 9,
177-181.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Swanton,
and
N.Jones
(2001).
Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products.
|
| |
Int J Exp Pathol, 82,
3.
|
 |
|
|
|
|
 |
C.Tarricone,
R.Dhavan,
J.Peng,
L.B.Areces,
L.H.Tsai,
and
A.Musacchio
(2001).
Structure and regulation of the CDK5-p25(nck5a) complex.
|
| |
Mol Cell, 8,
657-669.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.D.Jeffrey,
L.Tong,
and
N.P.Pavletich
(2000).
Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors.
|
| |
Genes Dev, 14,
3115-3125.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|